Cash Based Revenue

Sep 28 2026

Peptide Pharmacy Revenue: How Many Patients Do You Need?

By Dr. Lisa Faast | September 28, 2026 | Cash Based Revenue

The $10,000 Question: How Many Peptide Patients Do You Actually Need? The opportunity for peptide pharmacy revenue gets a whole lot more interesting when you stop talking about “market potential” and start doing the math. Because your patients aren’t waiting for independent pharmacies to discover peptides. They’re already hearing about them from providers, wellness clinics, […]

Jun 18 2026

Why Peptides Are Legally Allowed To Be OTC

By Dr. Lisa Faast | June 18, 2026 | Cash Based Revenue

Dear Pharmacy Owner, I’m about to make a statement about peptides that some people will disagree with. That’s okay. I’ve been in pharmacy long enough to know that some of the biggest opportunities often sound crazy when they first show up. I believe peptides may be the single biggest opportunity independent pharmacy has ever seen. […]

Dec 19 2025

Marijuana Reclassification: What the Pharmacy Impact Really Is

By Dr. Lisa Faast | December 19, 2025 | Cash Based Revenue

Headlines First, Reality Later If you’ve been in pharmacy longer than five minutes, you already know this routine. A president signs an executive order. The headlines go wild. Patients, staff, and random relatives at Thanksgiving ask: “So… does this change anything tomorrow?” Short answer: no. Long answer: also no — but something does start moving. […]

Nov 26 2025

8 Ways to Boost Pharmacy Profits in December

By Dr. Lisa Faast | November 26, 2025 | Cash Based Revenue

Don’t go holiday soft; boost your pharmacy profits easily with these December tips. December is basically the pharmacy owner’s version of running a relay race… while also wrapping presents… in a snow globe… with the phone ringing. The good news? It’s also one of the easiest months to quietly stack pharmacy profits —without feeling salesy […]

Cash-Based Services Every Independent Pharmacy Should Offer in 2025

By Dr. Lisa Faast | August 28, 2025 | Cash Based Revenue

Why Cash-Based Services Are Non-Negotiable in 2025 If you’re still relying on PBM reimbursements as your main source of revenue, you’re playing a losing game. Reimbursements are shrinking, DIR fees make brands on Medicare losers, and the “fill more to make more” model is dead. Adding cash-based services will create much-needed stability in your independent […]

Pharmacy vs Amazon Supplements: A Community-Driven Campaign for Patient Safety and Value

By Dr. Lisa Faast | August 7, 2025 | Cash Based Revenue

Tell your patients why they should get supplements from YOU and not from Amazon. Amazon can be great (thank you, grocery delivery), and it can be the Wild Wild West for supplements. Let’s set the record straight. When it comes to health, convenience shouldn’t mean compromise. And yet, millions of consumers are unknowingly buying low-quality […]

Jul 29 2025

Pharmacy Front-End Gold: How to Boost Sales

By Dr. Lisa Faast | July 29, 2025 | Cash Based Revenue

Boosting pharmacy front-end sales is as simple as consistency and training your team. You don’t need a fancy marketing funnel or high-pressure tactics to increase your average transaction size. What you need is a trained front-end team that knows how to have meaningful, helpful conversations with patients at checkout. Before you know it, your pharmacy […]

503B pharmacy dispensing for pharmacy profit

May 3 2025

Pharmacy Owners It’s Time To Get Fired Up About 503B Pharmacy Dispensing

By Dr. Lisa Faast | May 3, 2025 | Cash Based Revenue

If you’re like most pharmacy owners, you probably dipped your toe into the world of 503B pharmacy dispensing when compounded GLP-1s like semaglutide and tirzepatide started flying off the shelves. But here’s the thing—if you stopped there, you’re leaving a mountain of cash on the table. Dispensing sterile compounded prescriptions from 503B outsourcing facilities isn’t […]

Apr 29 2025

Should Pharmacies Keep Compounding GLP1s?

By Dr. Lisa Faast | April 29, 2025 | Cash Based Revenue

Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Here’s My Take. Howdy pharmacy peeps… Let’s have a real talk about compounding GLP1s. There’s been a lot of chatter lately in the pharmacy world—forums, Facebook groups, emails, even conference hallways—about whether pharmacies should keep compounding GLP1s tirzepatide/semaglutide once the FDA deadlines pass. […]

pharmacy profit with travel health services

Apr 22 2025

Boost Pharmacy Profit: Travel Health Services

By Dr. Lisa Faast | April 22, 2025 | Cash Based Revenue

Why your pharmacy should be the go-to destination for travel health services. (Hint: it will boost pharmacy profit and make patients love you!) I just finished planning and booking our family summer travel plans. Many people in your community are doing the same right now. To help make their travel the best it can be, […]